Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
In-Sun Hong, Gyu-Beom Jang, Hwa-Yong Lee & Jeong-Seok Nam. (2015) Targeting cancer stem cells by using the nanoparticles. International Journal of Nanomedicine 10:sup1, pages 251-260.
Read now
Read now
Pham Van Phuc, Phan Lu Chinh Nhan, Truong Hai Nhung, Nguyen Thanh Tam, Nguyen Minh Hoang, Vuong Gia Tue, Duong Thanh Thuy & Phan Kim Ngoc. (2011) Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24− breast cancer cells. OncoTargets and Therapy 4, pages 71-78.
Read now
Read now
Liang Cheng, Darrell D Davidson, Gregory T MacLennan, Sean R Williamson, Shaobo Zhang, Michael O Koch, Rodolfo Montironi & Antonio Lopez-Beltran. (2010) The origins of urothelial carcinoma. Expert Review of Anticancer Therapy 10:6, pages 865-880.
Read now
Read now
Articles from other publishers (79)
Sameh M. Farouk, Asmaa F. Khafaga & Ahmed M. Abdellatif. (2023) Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics. Cancer Cell International 23:1.
Crossref
Crossref
Amani Yehya, Joe Youssef, Sana Hachem, Jana Ismael & Wassim Abou-Kheir. (2023) Tissue-specific cancer stem/progenitor cells: Therapeutic implications. World Journal of Stem Cells 15:5, pages 323-341.
Crossref
Crossref
Guodong Chen, Yan Chen, Ruiquan Xu, Guoxi Zhang, Xiaofeng Zou & Gengqing Wu. (2022) Impact of SOX2 function and regulation on therapy resistance in bladder cancer. Frontiers in Oncology 12.
Crossref
Crossref
Kevina Sonawala, Satish Ramalingam & Iyappan Sellamuthu. (2022) Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways. Cells 11:21, pages 3492.
Crossref
Crossref
Jiufeng Tan, Yao Wang, Lihui Sun, Siqi Xu, Charles Li & Xuefei Jin. (2022) The Origin and Evolution of Bladder Cancer Stem Cells. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Yi Wei, Bastian Amend, Tilman Todenhöfer, Nizar Lipke, Wilhelm K. Aicher, Falko Fend, Arnulf Stenzl & Niklas Harland. (2022) Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems. International Journal of Molecular Sciences 23:11, pages 6305.
Crossref
Crossref
Jin Woo Lee & Hwa-Yong Lee. (2021) Targeting Cancer Stem Cell Markers or Pathways: A Potential Therapeutic Strategy for Oral Cancer Treatment. International Journal of Stem Cells 14:4, pages 386-399.
Crossref
Crossref
Georgios Kallifatidis, Kenza Mamouni & Bal Lokeshwar. (2020) The Role of β-Arrestins in Regulating Stem Cell Phenotypes in Normal and Tumorigenic Cells. International Journal of Molecular Sciences 21:23, pages 9310.
Crossref
Crossref
Amir Sadra Zangouei, Hamid Reza Rahimi, Majid Mojarrad & Meysam Moghbeli. (2020) Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells. Diagnostic Pathology 15:1.
Crossref
Crossref
Yaqi Qiu, Shi Qiu, Linghui Deng, Ling Nie, Lina Gong, Xinyang Liao, Xiaonan Zheng, Kun Jin, Jiakun Li, Xiang Tu, Liangren Liu, Zhenhua Liu, Yige Bao, Jianzhong Ai, Tianhai Lin, Lu Yang & Qiang Wei. (2020) Biomaterial 3D collagen I gel culture model: A novel approach to investigate tumorigenesis and dormancy of bladder cancer cells induced by tumor microenvironment. Biomaterials 256, pages 120217.
Crossref
Crossref
Zhao Yang, Haifeng Wang, Nan Zhang, Tianying Xing, Wei Zhang, Guoqing Wang, Chong Li & Changyuan Yu. (2020) Chaetocin Abrogates the Self-Renewal of Bladder Cancer Stem Cells via the Suppression of the KMT1A–GATA3–STAT3 Circuit. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Amira Abugomaa, Mohamed Elbadawy, Hideyuki Yamawaki, Tatsuya Usui & Kazuaki Sasaki. (2020) Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer. Cells 9:1, pages 235.
Crossref
Crossref
Ravi Gor & Satish Ramalingam. 2020. Cancer Stem Cells: New Horizons in Cancer Therapies. Cancer Stem Cells: New Horizons in Cancer Therapies
257
272
.
Chaohui Gu, Zhiyu Wang, Naichun Zhou, Guanru Li, Yiping Kou, Yang Luo, Yidi Wang, Jinjian Yang & Fengyan Tian. (2019) Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6-methyladenosine of Notch1. Molecular Cancer 18:1.
Crossref
Crossref
Mohamed Elbadawy, Tatsuya Usui, Takashi Mori, Ryouichi Tsunedomi, Shoichi Hazama, Rina Nabeta, Tsuyoshi Uchide, Ryuji Fukushima, Toshinori Yoshida, Makoto Shibutani, Takaharu Tanaka, Sosuke Masuda, Rena Okada, Ryo Ichikawa, Tsutomu Omatsu, Tetsuya Mizutani, Yukie Katayama, Shunsuke Noguchi, Satomi Iwai, Takayuki Nakagawa, Yuta Shinohara, Masahiro Kaneda, Hideyuki Yamawaki & Kazuaki Sasaki. (2019) Establishment of a novel experimental model for muscle‐invasive bladder cancer using a dog bladder cancer organoid culture. Cancer Science 110:9, pages 2806-2821.
Crossref
Crossref
Mingqing Wu, Lu Sheng, Maosheng Cheng, Haojie Zhang, Yizhou Jiang, Shuibin Lin, Yu Liang, Fengyu Zhu, Zhenqing Liu, Yingyin Zhang, Xiuhong Zhang, Qian Gao, Demeng Chen, Jiong Li & Yang Li. (2019) Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells. Oncogene 38:27, pages 5425-5439.
Crossref
Crossref
Anoop K. Yadav & Neetin S. Desai. (2019) Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects. Stem Cell Reviews and Reports 15:3, pages 331-355.
Crossref
Crossref
Nazi Aghaalikhani, Nadereh Rashtchizadeh, Pejman Shadpour, Abdolamir Allameh & Marzieh Mahmoodi. (2018) Cancer stem cells as a therapeutic target in bladder cancer. Journal of Cellular Physiology 234:4, pages 3197-3206.
Crossref
Crossref
David J. McConkey & Seth P. Lerner. (2018) SIU–ICUD consultation on bladder cancer: basic science. World Journal of Urology 37:1, pages 15-29.
Crossref
Crossref
May Yin Lee, Rajshekhar R. Giraddi & Wai Leong Tam. 2019. Chimera Research. Chimera Research
43
66
.
Chaohui Gu, Naichun Zhou, Zhiyu Wang, Guanru Li, Yipping Kou, Shunli Yu, Yongjie Feng, Long Chen, Jinjian Yang & Fengyan Tian. (2018) circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide. Molecular Therapy - Nucleic Acids 13, pages 633-641.
Crossref
Crossref
Rita Azevedo, Janine Soares, Cristiana Gaiteiro, Andreia Peixoto, Luís Lima, Dylan Ferreira, Marta Relvas-Santos, Elisabete Fernandes, Ana Tavares, Sofia Cotton, Ana Luísa Daniel-da-Silva, Lúcio Lara Santos, Rui Vitorino, Francisco Amado & José Alexandre Ferreira. (2018) Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer. Talanta 184, pages 347-355.
Crossref
Crossref
Md. Saiful Islam Roney & Song-Kyu Park. (2018) Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells. Archives of Pharmacal Research 41:4, pages 384-408.
Crossref
Crossref
Leili Saeednejad Zanjani, Zahra Madjd, Maryam Abolhasani, Arezoo Rasti, Oystein Fodstad, Yvonne Andersson & Mojgan Asgari. (2018) Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma. Biomarkers in Medicine 12:1, pages 45-61.
Crossref
Crossref
Rita Azevedo, Andreia Peixoto, Cristiana Gaiteiro, Elisabete Fernandes, Manuel Neves, Luís Lima, Lúcio Lara Santos & José Alexandre Ferreira. (2017) Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?. Oncotarget 8:53, pages 91734-91764.
Crossref
Crossref
Yi Li, Kaisu Lin, Zhao Yang, Ning Han, Xiaofang Quan, Xiangyang Guo & Chong Li. (2017) Bladder cancer stem cells: clonal origin and therapeutic perspectives. Oncotarget 8:39, pages 66668-66679.
Crossref
Crossref
Yuan-Yuan Xu, Ming Guo, Liu-Qing Yang, Fan Zhou, Cao Yu, Aixiu Wang, Tao-Hong Pang, Hong-Yan Wu, Xiao-Ping Zou, Wei-Jie Zhang, Lei Wang, Gui-Fang Xu & Qin Huang. (2017) Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance. Oncotarget 8:28, pages 45848-45861.
Crossref
Crossref
Alice Agliano, Alfonso Calvo & Carol Box. (2017) The challenge of targeting cancer stem cells to halt metastasis. Seminars in Cancer Biology 44, pages 25-42.
Crossref
Crossref
Caihong Wang, Whitney Trotter Ross & Indira U. Mysorekar. (2017) Urothelial generation and regeneration in development, injury, and cancer. Developmental Dynamics 246:4, pages 336-343.
Crossref
Crossref
Shirin Sedaghat, Elmira Gheytanchi, Mojgan Asgari, Raheleh Roudi, Hossein Keymoosi & Zahra Madjd. (2017) Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas. Applied Immunohistochemistry & Molecular Morphology 25:3, pages 196-202.
Crossref
Crossref
Shosuke Kawanishi, Shiho Ohnishi, Ning Ma, Yusuke Hiraku, Shinji Oikawa & Mariko Murata. (2017) Nitrative and oxidative DNA damage in infection-related carcinogenesis in relation to cancer stem cells. Genes and Environment 38:1.
Crossref
Crossref
Aniruddha Roy & Shyh‐Dar Li. (2016) Modifying the tumor microenvironment using nanoparticle therapeutics. WIREs Nanomedicine and Nanobiotechnology 8:6, pages 891-908.
Crossref
Crossref
Takeshi Motohara, Koichi Fujimoto, Shingo Tayama, Dashdemberel Narantuya, Isao Sakaguchi, Hironori Tashiro & Hidetaka Katabuchi. (2016) CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer. Obstetrics & Gynecology 127:6, pages 1003-1011.
Crossref
Crossref
Fujin Jiang, Song Ma, Yubao Xue, Jianquan Hou & Yongjie Zhang. (2016) LDH-A promotes malignant progression via activation of epithelial-to-mesenchymal transition and conferring stemness in muscle-invasive bladder cancer. Biochemical and Biophysical Research Communications 469:4, pages 985-992.
Crossref
Crossref
A.V. Kurtova & K.S. Chan. 2016. Cancer Stem Cells. Cancer Stem Cells
211
229
.
Tomokazu Ohishi, Fumitaka Koga & Toshiro Migita. (2015) Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives. International Journal of Molecular Sciences 17:1, pages 43.
Crossref
Crossref
Minal Garg. (2015) Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer. Cancer and Metastasis Reviews 34:4, pages 691-701.
Crossref
Crossref
Francisca Tjhay, Takeshi Motohara, Shingo Tayama, Dashdemberel Narantuya, Koichi Fujimoto, Jianying Guo, Isao Sakaguchi, Ritsuo Honda, Hironori Tashiro & Hidetaka Katabuchi. (2015)
CD
44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
. Cancer Science 106:10, pages 1421-1428.
Crossref
Crossref
April Adams, Kristy Warner, Alexander T. Pearson, Zhaocheng Zhang, Hong Sun Kim, Daiki Mochizuki, Gregory Basura, Joseph Helman, Andrea Mantesso, Rogério M. Castilho, Max S. Wicha & Jacques E. Nör. (2015) ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas. Oncotarget 6:29, pages 26633-26650.
Crossref
Crossref
Keith Syson Chan & David J. McConkey. 2015. Bladder cancer. Bladder cancer
342
352
.
Ning Xu, Ming-Ming Shao, Hai-Tao Zhang, Mei-Shan Jin, Yi Dong, Ren-Jie Ou, Hai-Ming Wang & Ai-Ping Shi. (2015) Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer. Cancer Epidemiology 39:3, pages 375-381.
Crossref
Crossref
Y Yang, H Xu, J Shen, Y Yang, S Wu, J Xiao, Y Xu, X-Y Liu & L Chu. (2015) RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells. Cell Death & Disease 6:5, pages e1760-e1760.
Crossref
Crossref
Shiyi Yu, Xiuxiu Cai, Chenxi Wu, Lele Wu, Yuzhi Wang, Yan Liu, Zhenghong Yu, Sheng Qin, Fei Ma, Jean Paul Thiery & Liming Chen. (2014) Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression. Oncotarget 6:5, pages 2951-2965.
Crossref
Crossref
Sangeetha Krishnamurthy, Xiyu Ke & Yi Yan Yang. (2015) Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells. Nanomedicine 10:1, pages 143-160.
Crossref
Crossref
Jiahui Liu & Zhichong Wang. (2015) Increased Oxidative Stress as a Selective Anticancer Therapy. Oxidative Medicine and Cellular Longevity 2015, pages 1-12.
Crossref
Crossref
Monica Mangoni, Mariangela Sottili, Mauro Loi, Chiara Gerini, Icro Meattini & Lorenzo Livi. 2015. Cancer Immunology. Cancer Immunology
151
176
.
Donatella Conconi, Elena Panzeri, Serena Redaelli, Giorgio Bovo, Paolo Viganò, Guido Strada, Leda Dalprà & Angela Bentivegna. (2014) Chromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cells. BMC Cancer 14:1.
Crossref
Crossref
Jie Ni, Paul J. Cozzi, Jing L. Hao, Julia Beretov, Lei Chang, Wei Duan, Sarah Shigdar, Warick J. Delprado, Peter H. Graham, Joseph Bucci, John H. Kearsley & Yong Li. (2014) CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance. The Prostate 74:6, pages 602-617.
Crossref
Crossref
Garrett M. Dancik, Charles R. Owens, Kenneth A. Iczkowski & Dan Theodorescu. (2014) A Cell of Origin Gene Signature Indicates Human Bladder Cancer Has Distinct Cellular Progenitors. Stem Cells 32:4, pages 974-982.
Crossref
Crossref
Hossein Keymoosi, Elmira Gheytanchi, Mojgan Asgari, Ahmad Shariftabrizi & Zahra Madjd. (2014) ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder. Asian Pacific Journal of Cancer Prevention 15:5, pages 2013-2020.
Crossref
Crossref
Souichi Yanamoto. (2014) Expression of the cancer stem cell markers CD44v6 and ABCG2 in tongue cancer: Effect of neoadjuvant chemotherapy on local recurrence. International Journal of Oncology.
Crossref
Crossref
Heng Li, Gan Yu, Runlin Shi, Bin Lang, Xianguo Chen, Ding Xia, Haibing Xiao, Xiaolin Guo, Wei Guan, Zhangqun Ye, Wei Xiao & Hua Xu. (2014) Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Molecular Cancer 13:1.
Crossref
Crossref
Luís León Mateos, Martín Lázaro Quintela, Sergio Vázquez Estévez & Luis Antón Aparicio. 2014. Stem Cells in Cancer: Should We Believe or Not?. Stem Cells in Cancer: Should We Believe or Not?
149
165
.
Weihua Lan, Dianzheng Zhang & Jun Jiang. (2013) The roles of LSD1-mediated epigenetic modifications in maintaining the pluripotency of bladder cancer stem cells. Medical Hypotheses 81:5, pages 823-825.
Crossref
Crossref
Yong-Rui Du, Ying Chen, Yan Gao, Xiu-Long Niu, Ya-Jing Li & Wei-Min Deng. (2013) Effects and Mechanisms of Anti-CD44 Monoclonal Antibody A3D8 on Proliferation and Apoptosis of Sphere-Forming Cells With Stemness From Human Ovarian Cancer. International Journal of Gynecological Cancer 23:8, pages 1367-1375.
Crossref
Crossref
Shan-Yong Yi, Yi-Bin Hao, Ke-Jun Nan & Tian-Li Fan. (2013) Cancer stem cells niche: A target for novel cancer therapeutics. Cancer Treatment Reviews 39:3, pages 290-296.
Crossref
Crossref
Timothy E. Andrews, Dan Wang & Daniel A. Harki. (2012) Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery. Drug Delivery and Translational Research 3:2, pages 121-142.
Crossref
Crossref
Shiho Ohnishi, Ning Ma, Raynoo Thanan, Somchai Pinlaor, Olfat Hammam, Mariko Murata & Shosuke Kawanishi. (2013) DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells. Oxidative Medicine and Cellular Longevity 2013, pages 1-9.
Crossref
Crossref
Liping Li, Bingkun Li, Jialiang Shao & Xiang Wang. (2012) Chemotherapy sorting can be used to identify cancer stem cell populations. Molecular Biology Reports 39:11, pages 9955-9963.
Crossref
Crossref
Philip Levy Ho, Antonina Kurtova & Keith Syson Chan. (2012) Normal and neoplastic urothelial stem cells: getting to the root of the problem. Nature Reviews Urology 9:10, pages 583-594.
Crossref
Crossref
Yi Zhang, Zhi Wang, Jin Yu, Jia zhong Shi, Chun Wang, Wei hua Fu, Zhi wen Chen & Jin Yang. (2012) Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer. Cancer Letters 322:1, pages 70-77.
Crossref
Crossref
Geertje van der Horst, Lieke Bos & Gabri van der Pluijm. (2012) Epithelial Plasticity, Cancer Stem Cells, and the Tumor-Supportive Stroma in Bladder Carcinoma. Molecular Cancer Research 10:8, pages 995-1009.
Crossref
Crossref
Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology
137
159
.
Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology
707
733
.
Thomas B. Brunner, Leoni A. Kunz-Schughart, Philipp Grosse-Gehling & Michael Baumann. (2012) Cancer Stem Cells as a Predictive Factor in Radiotherapy. Seminars in Radiation Oncology 22:2, pages 151-174.
Crossref
Crossref
Miriam Romaguera-Ros, María Peris-Celda, Jorge Oliver-De La Cruz, Josefa Carrión-Navarro, Arantxa Pérez-García, Jose Manuel García-Verdugo & Angel Ayuso-Sacido. (2011) Cancer-Initiating Enriched Cell Lines from Human Glioblastoma: Preparing for Drug Discovery Assays. Stem Cell Reviews and Reports 8:1, pages 288-298.
Crossref
Crossref
Jens-Peter VolkmerDebashis SahooRobert K. ChinPhilip Levy Ho, Chad TangAntonina V. Kurtova, Stephen B. WillinghamSenthil K. Pazhanisamy, Humberto Contreras-TrujilloTheresa A. StormYair LotanAndrew H. BeckBenjamin I. ChungAsh A. AlizadehGuilherme Godoy, Seth P. Lerner, Matt van de RijnLinda D. ShortliffeIrving L. WeissmanKeith S. Chan. (2012) Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proceedings of the National Academy of Sciences 109:6, pages 2078-2083.
Crossref
Crossref
Raynoo Thanan, Mariko Murata, Ning Ma, Olfat Hammam, Mohamed Wishahi, Tarek El Leithy, Yusuke Hiraku, Shinji Oikawa & Shosuke Kawanishi. (2012) Nuclear Localization of COX-2 in relation to the Expression of Stemness Markers in Urinary Bladder Cancer. Mediators of Inflammation 2012, pages 1-8.
Crossref
Crossref
Mayumi Jijiwa, Habibe Demir, Snehalata Gupta, Crystal Leung, Kaushal Joshi, Nicholas Orozco, Tiffany Huang, Vedat O. Yildiz, Ichiyo Shibahara, Jason A. de Jesus, William H. Yong, Paul S. Mischel, Soledad Fernandez, Harley I. Kornblum & Ichiro Nakano. (2011) CD44v6 Regulates Growth of Brain Tumor Stem Cells Partially through the AKT-Mediated Pathway. PLoS ONE 6:9, pages e24217.
Crossref
Crossref
Liang Cheng, Shaobo Zhang, Gregory T. MacLennan, Sean R. Williamson, Antonio Lopez-Beltran & Rodolfo Montironi. (2011) Bladder cancer: translating molecular genetic insights into clinical practice. Human Pathology 42:4, pages 455-481.
Crossref
Crossref
Minako Hagikura, Yoshiki Murakumo, Masaki Hasegawa, Mayumi Jijiwa, Sumitaka Hagiwara, Shinji Mii, Shoichi Hagikura, Yoshihisa Matsukawa, Yasushi Yoshino, Ryohei Hattori, Kenji Wakai, Shigeo Nakamura, Momokazu Gotoh & Masahide Takahashi. (2010) Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression. Pathology International 60:11, pages 735-743.
Crossref
Crossref
Craig Gedye, Adee-Jonathan Davidson, Martin R. Elmes, Jonathan Cebon, Damien Bolton & Ian D. Davis. (2010) Cancer stem cells in urologic cancers. Urologic Oncology: Seminars and Original Investigations 28:6, pages 585-590.
Crossref
Crossref
Keith Syson Chan, Jens-Peter Volkmer & Irving Weissman. (2010) Cancer stem cells in bladder cancer: a revisited and evolving concept. Current Opinion in Urology 20:5, pages 393-397.
Crossref
Crossref
Tobias Klatte, David B. Seligson, Jian Yu Rao, Hong Yu, Michela de Martino, Isla Garraway, Steven G. Wong, Arie S. Belldegrun & Allan J. Pantuck. (2010) Absent CD44v6 Expression is an Independent Predictor of Poor Urothelial Bladder Cancer Outcome. Journal of Urology 183:6, pages 2403-2408.
Crossref
Crossref
Yun Su, Qi Qiu, Xingqiao Zhang, Zhengran Jiang, Qixin Leng, Zhenqiu Liu, Sanford A. Stass & Feng Jiang. (2010) Aldehyde Dehydrogenase 1 A1–Positive Cell Population Is Enriched in Tumor-Initiating Cells and Associated with Progression of Bladder Cancer. Cancer Epidemiology, Biomarkers & Prevention 19:2, pages 327-337.
Crossref
Crossref
Paola Gazzaniga, Giuseppe Naso, Angela Gradilone, Enrico Cortesi, Orietta Gandini, Walter Gianni, Maria Agnese Fabbri, Bruno Vincenzi, Franco di Silverio, Luigi Frati, Anna Maria Aglianò & Massimo Cristofanilli. (2010) Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors. International Journal of Cancer, pages NA-NA.
Crossref
Crossref
William D. Brandt, William Matsui, Jonathan E. Rosenberg, Xiaobing He, Shizhang Ling, Edward M. Schaeffer & David M. Berman. (2009) Urothelial carcinoma: Stem cells on the edge. Cancer and Metastasis Reviews 28:3-4, pages 291-304.
Crossref
Crossref
Liang ChengShaobo Zhang, Darrell D Davidson, Gregory T MacLennan, Michael O Koch, Rodolfo Montironi & Antonio Lopez-Beltran. (2009) Molecular determinants of tumor recurrence in the urinary bladder. Future Oncology 5:6, pages 843-857.
Crossref
Crossref
Xiaobing He, Luigi Marchionni, Donna E. Hansel, Wayne Yu, Akshay Sood, Jie Yang, Giovanni Parmigiani, William Matsui & David M. Berman. (2009) Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial Carcinoma. Stem Cells 27:7, pages 1487-1495.
Crossref
Crossref